CIK 0001090872 · Laboratory Analytical Instruments (SIC 3826) · NYSE · incorporated in DE · fiscal year ends 10/31
| FY2025 | FY2022 | |
|---|---|---|
| Revenue (USD) | 6.9 B | 5.3 B |
| Net income (USD) | 1.3 B | 719.0 M |
| Diluted EPS (USD/shares) | 4.57 | 2.3 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-23 | EFFECT | EFFECT items ,, | |
| 2026-09-23 | 424B3 | 424B3 | |
| 2026-09-10 | 4 | PRIMARY DOCUMENT | 2026-09-08 |
| 2026-09-10 | 3 | PRIMARY DOCUMENT | 2026-09-04 |
| 2026-09-09 | 4 | PRIMARY DOCUMENT | 2026-09-04 |
| 2026-09-08 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-09-02 |
| 2026-09-04 | 144 | 144 | |
| 2026-09-01 | S-4 | S-4 | |
| 2026-09-01 | S-3ASR | S-3ASR | |
| 2026-09-01 | 10-Q | 10-Q | 2026-07-31 |
| 2026-08-26 | 8-K | 8-K items 2.02,9.01 | 2026-08-26 |
| 2026-06-29 | 4 | PRIMARY DOCUMENT | 2026-06-26 |
| 2026-06-25 | 8-K | 8-K items 1.01,2.03,9.01 | 2026-06-25 |
| 2026-06-05 | 3 | PRIMARY DOCUMENT | 2026-06-02 |
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 2026-06-03 |
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 2026-05-29 |
| 2026-06-01 | 10-Q | 10-Q | 2026-04-30 |
| 2026-05-29 | 144 | 144 | |
| 2026-05-29 | SD | SD | |
| 2026-05-27 | 8-K | 8-K items 2.02,5.02,9.01 | 2026-05-20 |
| 2026-05-21 | 4 | PRIMARY DOCUMENT | 2026-05-19 |
| 2026-05-12 | 4 | PRIMARY DOCUMENT | 2026-05-08 |
| 2026-05-08 | 3 | PRIMARY DOCUMENT | 2026-05-04 |
| 2026-05-04 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-05-04 |
| 2026-04-29 | SCHEDULE 13G | SCHEDULE 13G |
Forms on file (last 1,000): 4 649, 8-K 105, 144 38, 4/A 37, 10-Q 30, SC 13G/A 29, 3 21, DEFA14A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=A (0.002 USD), /gw/filings/filings?ticker=A&form=8-K, /gw/filings/facts?ticker=A&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange